Meiling Hu
Impact in
- Pharmaceutical Science top 5%
- Advancements in Transdermal Drug Delivery
- Cancer Research top 10%
- Cancer, Hypoxia, and Metabolism
Papers in
- Oncology 9
- Cancer Immunotherapy and Biomarkers 4
- Global Cancer Incidence and Screening 2
-
- Cancer-related molecular mechanisms research 2
- Cancer, Hypoxia, and Metabolism 2
- Co-authors
- Hongli Du (11 shared papers)Jinfen Wei (9 shared papers)Shudai Lin (5 shared papers)Zixi Chen (7 shared papers)Yunmeng Bai (4 shared papers)Lin Chen (2 shared papers)Jianying Li (2 shared papers)Xianlong Zhang (2 shared papers)
- Journals
- International Journal of Molecular Sciences (3 papers)Frontiers in Immunology (2 papers)International Journal of Infectious Diseases (1 paper)Agronomy (1 paper)Epigenomics (1 paper)
- Partner nations
- ChinaUnited StatesIndia
In The Last Decade
Meiling Hu
53 papers receiving 1.1k citations
Meiling Hu's Hit Papers
Peers
Comparison fields: 5 of 103
- Pharmaceutical Science 114
- Cancer Research 119
- Health Informatics 15
- Oncology 122
- Plant Science 205
Countries citing papers authored by Meiling Hu
This map shows the geographic impact of Meiling Hu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Meiling Hu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Meiling Hu more than expected).
Fields of papers citing papers by Meiling Hu
This network shows the impact of papers produced by Meiling Hu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Meiling Hu. The network helps show where Meiling Hu may publish in the future.
Co-authors
The 25 scholars most cited alongside Meiling Hu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 56 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2008 | 130 | |
| 2 | 2020 | 128 | |
| 3 | 2020 | 89 | |
| 4 | 2018 | 77 | |
| 5 | 2021 | 68 | |
| 6 | 2017 | 66 | |
| 7 | 2021 | 55 | |
| 8 | 2018 | 39 | |
| 9 | 2020 | 29 | |
| 10 | 2014 | 25 | |
| 11 | 2024 | 25 | |
| 12 | 2022 | 24 | |
| 13 | Regulatory approaches towards AI Medical Devices: A comparative study of the United States, the European Union and China Hit paper breakdown → | 2025 | 24 |
| 14 | 2020 | 22 | |
| 15 | 2023 | 22 | |
| 16 | 2012 | 19 | |
| 17 | 2023 | 18 | |
| 18 | 2018 | 14 | |
| 19 | 2023 | 14 | |
| 20 | 2018 | 13 |
About Meiling Hu
Meiling Hu is a scholar working on Oncology, Cancer Research, Plant Science, Pathology and Forensic Medicine and Molecular Biology, having authored 56 papers that have together received 1.1k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (4 papers), Cardiac Fibrosis and Remodeling (3 papers), Cancer-related molecular mechanisms research (2 papers), Global Cancer Incidence and Screening (2 papers), Plant Stress Responses and Tolerance (2 papers), Research in Cotton Cultivation (2 papers), Cancer, Hypoxia, and Metabolism (2 papers) and Immune cells in cancer (2 papers). The work is most often cited by research in Pharmaceutical Science (114 citations), Cancer Research (119 citations), Health Informatics (15 citations), Oncology (122 citations) and Plant Science (205 citations). Meiling Hu has collaborated with scholars based in China, United States and India. Frequent co-authors include Hongli Du, Jinfen Wei, Shudai Lin, Zixi Chen, Yunmeng Bai, Lin Chen, Jianying Li, Xianlong Zhang, Xiyan Yang and Heng Sun. Their work appears in journals such as International Journal of Molecular Sciences, Frontiers in Immunology, International Journal of Infectious Diseases, Agronomy and Epigenomics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.